JPS5742651A - Non-hygroscopic salt of 4-hydroxybutyric acid, manufacture and drug containing same - Google Patents

Non-hygroscopic salt of 4-hydroxybutyric acid, manufacture and drug containing same

Info

Publication number
JPS5742651A
JPS5742651A JP11151481A JP11151481A JPS5742651A JP S5742651 A JPS5742651 A JP S5742651A JP 11151481 A JP11151481 A JP 11151481A JP 11151481 A JP11151481 A JP 11151481A JP S5742651 A JPS5742651 A JP S5742651A
Authority
JP
Japan
Prior art keywords
manufacture
hydroxybutyric acid
drug containing
containing same
hygroscopic salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP11151481A
Other languages
Japanese (ja)
Inventor
Kurosa Yozefu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPS5742651A publication Critical patent/JPS5742651A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP11151481A 1980-07-17 1981-07-16 Non-hygroscopic salt of 4-hydroxybutyric acid, manufacture and drug containing same Pending JPS5742651A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3027390 1980-07-17

Publications (1)

Publication Number Publication Date
JPS5742651A true JPS5742651A (en) 1982-03-10

Family

ID=6107582

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11151481A Pending JPS5742651A (en) 1980-07-17 1981-07-16 Non-hygroscopic salt of 4-hydroxybutyric acid, manufacture and drug containing same

Country Status (2)

Country Link
JP (1) JPS5742651A (en)
ZA (1) ZA814854B (en)

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54131665A (en) * 1978-04-04 1979-10-12 Chugai Shashin Yakuhin Production of porous resin
JP2005532362A (en) * 2002-06-13 2005-10-27 ノバルティス アクチエンゲゼルシャフト Calcium salt of indole-derived statin
JP2007195729A (en) * 2006-01-26 2007-08-09 Ntt Facilities Inc Furniture for storage
US7851506B2 (en) 1998-12-23 2010-12-14 Jazz Pharmaceuticals, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
US8591922B1 (en) 2012-12-14 2013-11-26 Jazz Pharmacuticals, Inc. Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
JP2014513046A (en) * 2011-02-14 2014-05-29 コンサート ファーマシューティカルズ インコーポレイテッド Deuterated analog of 4-hydroxybutyric acid
US8771735B2 (en) 2008-11-04 2014-07-08 Jazz Pharmaceuticals, Inc. Immediate release dosage forms of sodium oxybate
US8778398B2 (en) 2008-11-04 2014-07-15 Jazz Pharmaceuticals, Inc. Immediate release formulations and dosage forms of gamma-hydroxybutyrate
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US10532971B2 (en) 2009-04-23 2020-01-14 Concert Pharmaceuticals, Inc. 4-hydroxybutyric acid analogs
US10758488B2 (en) 2010-03-24 2020-09-01 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
US11400052B2 (en) 2018-11-19 2022-08-02 Jazz Pharmaceuticals Ireland Limited Alcohol-resistant drug formulations
US11400065B2 (en) 2019-03-01 2022-08-02 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
US11426373B2 (en) 2017-03-17 2022-08-30 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11839597B2 (en) 2016-07-22 2023-12-12 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12097175B2 (en) 2023-09-14 2024-09-24 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Cited By (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54131665A (en) * 1978-04-04 1979-10-12 Chugai Shashin Yakuhin Production of porous resin
JPS6136535B2 (en) * 1978-04-04 1986-08-19 Chugai Shashin Yakuhin Kk
US8859619B2 (en) 1998-12-23 2014-10-14 Jazz Pharmaceuticals, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
US9539330B2 (en) 1998-12-23 2017-01-10 Jazz Pharmaceuticals, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
US7851506B2 (en) 1998-12-23 2010-12-14 Jazz Pharmaceuticals, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
US8263650B2 (en) 1998-12-23 2012-09-11 Jazz Pharmaceuticals, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
US8324275B2 (en) 1998-12-23 2012-12-04 Jazz Pharmaceuticals, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
US8461203B2 (en) 1998-12-23 2013-06-11 Jazz Pharmaceuticals, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
US8952062B2 (en) 1998-12-23 2015-02-10 Jazz Pharmaceuticals, Inc. Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
JP2005532362A (en) * 2002-06-13 2005-10-27 ノバルティス アクチエンゲゼルシャフト Calcium salt of indole-derived statin
JP2007195729A (en) * 2006-01-26 2007-08-09 Ntt Facilities Inc Furniture for storage
US8771735B2 (en) 2008-11-04 2014-07-08 Jazz Pharmaceuticals, Inc. Immediate release dosage forms of sodium oxybate
US8778398B2 (en) 2008-11-04 2014-07-15 Jazz Pharmaceuticals, Inc. Immediate release formulations and dosage forms of gamma-hydroxybutyrate
US9795567B2 (en) 2008-11-04 2017-10-24 Jazz Pharmaceuticals, Inc. Immediate release formulations and dosage forms of gamma-hydroxybutyrate
US11161798B2 (en) 2009-04-23 2021-11-02 Concert Pharmaceuticals, Inc. 4-hydroxybutyric acid analogs
US11939285B2 (en) 2009-04-23 2024-03-26 Sun Pharmaceutical Industries, Inc. 4-hydroxybutyric acid analogs
US10532971B2 (en) 2009-04-23 2020-01-14 Concert Pharmaceuticals, Inc. 4-hydroxybutyric acid analogs
US10813885B1 (en) 2010-03-24 2020-10-27 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
US10959956B2 (en) 2010-03-24 2021-03-30 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
US11207270B2 (en) 2010-03-24 2021-12-28 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
US11090269B1 (en) 2010-03-24 2021-08-17 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
US10987310B2 (en) 2010-03-24 2021-04-27 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
US10966931B2 (en) 2010-03-24 2021-04-06 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
US10758488B2 (en) 2010-03-24 2020-09-01 Jazz Pharmaceuticals, Inc. Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
JP2017165747A (en) * 2011-02-14 2017-09-21 コンサート ファーマシューティカルズ インコーポレイテッド 4-hydroxybutyric acid deuterated analogs
JP2014513046A (en) * 2011-02-14 2014-05-29 コンサート ファーマシューティカルズ インコーポレイテッド Deuterated analog of 4-hydroxybutyric acid
US8901173B2 (en) 2012-12-14 2014-12-02 Jazz Pharmacuticals, Inc. Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US9555017B2 (en) 2012-12-14 2017-01-31 Jazz Pharmaceuticals Ireland Limited Methods of making a mixture of salts of gamma-hydroxybutyrate
US10675258B2 (en) 2012-12-14 2020-06-09 Jazz Pharmaceuticals Ireland Limited Method of using gamma-hydroxybutyrate compositions for the treatment of disorders
US9132107B2 (en) 2012-12-14 2015-09-15 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US10195168B2 (en) 2012-12-14 2019-02-05 Jazz Pharmaceuticlas Ireland Limited Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders
JP2016503762A (en) * 2012-12-14 2016-02-08 ジャズ ファーマシューティカルス アイルランド リミテッド Gamma-hydroxybutyrate composition and its use for the treatment of disease
US8591922B1 (en) 2012-12-14 2013-11-26 Jazz Pharmacuticals, Inc. Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US11554102B2 (en) 2012-12-14 2023-01-17 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their uses for the treatment of disorders
US11077079B1 (en) 2015-02-18 2021-08-03 Jazz Pharmaceuticals Ireland Limited GHB formulation and method for its manufacture
US10398662B1 (en) 2015-02-18 2019-09-03 Jazz Pharma Ireland Limited GHB formulation and method for its manufacture
US11147782B1 (en) 2015-02-18 2021-10-19 Jazz Pharmaceuticals Ireland Limited GHB formulation and method for its manufacture
US11364215B1 (en) 2015-02-18 2022-06-21 Jazz Pharmaceuticals Ireland Limited GHB formulation and method for its manufacture
US11504347B1 (en) 2016-07-22 2022-11-22 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11896572B2 (en) 2016-07-22 2024-02-13 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11986451B1 (en) 2016-07-22 2024-05-21 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11839597B2 (en) 2016-07-22 2023-12-12 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602513B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11602512B1 (en) 2016-07-22 2023-03-14 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11766418B2 (en) 2016-07-22 2023-09-26 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11826335B2 (en) 2016-07-22 2023-11-28 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11426373B2 (en) 2017-03-17 2022-08-30 Jazz Pharmaceuticals Ireland Limited Gamma-hydroxybutyrate compositions and their use for the treatment of disorders
US11400052B2 (en) 2018-11-19 2022-08-02 Jazz Pharmaceuticals Ireland Limited Alcohol-resistant drug formulations
US11400065B2 (en) 2019-03-01 2022-08-02 Flamel Ireland Limited Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
US11779557B1 (en) 2022-02-07 2023-10-10 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US11583510B1 (en) 2022-02-07 2023-02-21 Flamel Ireland Limited Methods of administering gamma hydroxybutyrate formulations after a high-fat meal
US12097175B2 (en) 2023-09-14 2024-09-24 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
US12097176B2 (en) 2023-11-10 2024-09-24 Flamel Ireland Limited Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Also Published As

Publication number Publication date
ZA814854B (en) 1982-07-28

Similar Documents

Publication Publication Date Title
JPS5742651A (en) Non-hygroscopic salt of 4-hydroxybutyric acid, manufacture and drug containing same
DE3171354D1 (en) Imidazolylpropanol compounds and their acid addition salts, and production and use thereof
NZ198106A (en) Pharmaceutical powder containing microencapsulated bacampicillin acid addition salt
JPS57159772A (en) 3,4-dihydro-5h-2,3-benzodiazepine derivatives, acid addition salts, manufacture and medicinal composition containing them
JPS5798281A (en) Azabicyclooctane-carboxylic acid, manufacture and pharmaceutical composition containing same
JPS57144219A (en) Azobissalicylic acid and salts thereof and medicinal composition containing them
IL62960A (en) Imidazoazolepropenoic acid amides,their production and pharmaceutical compositions containing them
JPS56154417A (en) Use of 3,3'-azobis -(6-hydroxybenzoic acid) as drug and pharmaceutical composition containing it
IL62912A0 (en) Penam-3-carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
ZA812672B (en) Use as medicaments of substituted derivatives of 4-phenyl-4-oxo-2-butenoic acid
JPS57183736A (en) Novel derivative of phenylaliphatic carboxylic acid, manufacture, use as drug and composition containing same
IL75322A (en) Herbicide antidotes containing benzoxazolyl-and benzothiazolyl-amino acid derivatives,some novel compounds of this type and process for their preparation
JPS5681569A (en) Salt of dihaloo22quinoxalinecarboxylic acid
JPS5672020A (en) Manufacture of polyamine acid
JPS57123197A (en) Manufacture of 1-aminoalkane-1,1-diphosphoric acid
JPS57181057A (en) Manufacture of 4-amino-3,5,6-trichloropicolinic acid
PH17057A (en) Kijanimicin and salts thereof,pharmaceutical compositions containing same and process of preparring same
DE3175699D1 (en) Salts and aqueous solutions of 6-methylamino-4-oxo-10-propyl-4h-pyrano(3,2-g)-quinoline-2,8-di-carboxylic acid and pharmaceutical compositions containing such salts and solutions
GB2036748B (en) Silver salts of phosphanilic acid
JPS57108059A (en) Manufacture of 1,4-diamino-anthraquinone-2- sulfonic acid
IL69858A (en) 2-phenoxypropionic acid derivatives of pentites,processes for their preparation and herbicidal compositions containing them
IL62326A0 (en) 7 beta-amido-3-cephem-4-carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
JPS568362A (en) Manufacture of 55aroyll11lower alkylpyrrolee 22acetic acid salt
JPS56140968A (en) Manufacture of carbamoylsulfonic acid derivative salt
JPS57159780A (en) 1-oxide nicotic acid thioalkylamide, salt thereof, manufacture and pharmaceucological composition